Search This Blog

Monday, December 9, 2024

Innate Pharma Presents Phase 2 Study in Cutaneous T Cell Lymphoma

 

  • Findings reveal promising early signs that lacutamab may help alleviate some of the most distressing symptoms of cutaneous T cell lymphomas
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)